Open mobile menu
Model.SiteSettings!.GetInTouchLink!.Name Contact Us
Jroberts Jruaux Dpingstone 03 B012378 CROPPED
Insights

News

Stay up to date with news about Secerna and intellectual property topics.

WAKIX (1)

A to Z: Drugs in Highlight: W is for WAKIX®

News A to Z Feature 08/05/2025

Our A to Z series highlights WAKIX® (from Bioprojet Pharma) which is used to treat narcolepsy in adults, adolescents and children from 6 years of age. The active substance in WAKIX® is pitolisant. Pitolisant works by blocking histamine from attaching to the histamine H3 receptor on nerve cells.

Read more
Cells
Events 05/10/2021

Biovale Workshop for Biological Enterprises

Plants 14.10.21
Industry news 01/10/2021

What the change in gene editing regulations means for IP in the UK

Dermot Roche Press 800X800px Colour Temp Pic
Events 22/09/2021

IPBC Europe: Leadership Summit

Telecoms Tower
Industry news 16/09/2021

5G Technology Patent Protection and Licensing

News203
European, News 08/09/2021

Patenting Medical Devices at the European Patent Office

Video Meeting
European, News 06/09/2021

Oral Proceedings by Video at the EU Patent Offce

IP CHW
News 23/08/2021

UK IPO IP Access grants

Mirror Image
European, News 28/07/2021

Double patenting at the European Patent Office

EPO 2021
European, Industry news 15/07/2021

T 0116/18 - a new plausibility threshold for post-filing data?

22 23 24 25 26 27 28 29 30 31 32